Board of Directors

andrew-kay-photo (2)

Andrew Kay

Born 1955. Chairman of the Board since 2015. Member of the audit committee.

  • Education: BPharm Hons, Nottingham University.
  • Other current assignments: Chairman of Blueberry Therapeutics, director of Amulet Consulting and senior advisor of HealthCap.
  • Previous assignments (last five years): CEO of Algeta ASA.
  • Position: Independent of the Company, executive management and major shareholders.
  • Holdings in the Company: 7,088 shares,  255,000 stock options and 24,000 performance shares Board LTIP 2016.

dina-chaya-photo

Dina Chaya

Born 1971. Board Member since 2015.

  • Education: CFA charterholder, CFA Institute and BSc in natural sciences tripos, Cambridge University and MSc in development biology and PhD in molecular and cellular biology of development, Paris VI University.
  • Other current assignments: Partner of NeoMed Management (Jersey) Limited. Board member of Oxular Ltd, TopiVert Ltd and TopiVert Pharma Ltd.
  • Previous assignments (last five years): None.
  • Position: Independent of the Company, executive management and major shareholders.
  • Holdings in the Company: None.

genghis-lloyd-harris-photo

Genghis Lloyd-Harris

Born 1957. Board Member since 2014. Chairman of audit committee and member of the remuneration committee.

  • Education: MBA, Harvard University, PhD in pharmacology, University of Melbourne, MB ChB Hons in medicine and BSc Hons in biochemistry, University of Liverpool.
  • Other current assignments: Board member of Abingworth LLP, Abingworth Avillion Blocker Limited, Avillion LLP and Gensight Biologics SA.
  • Previous assignments (last five years): Board member of Healthcare Brands and Syntaxin Limited.
  • Position: Independent of the Company and executive management. Dependent to major shareholders.
  • Holdings in the Company: 90,000 shares.

bali-muralidhar-photo

Bali Muralidhar

Born 1979. Board Member since 2014. Member of the audit committee.

  • Education: BMBCh in clinical medicine, Oxford University. MA in medical sciences and Ph.D. in cancer biology, Cambridge University.
  • Other current assignments: Board member of Onbone Oy, AP Brands and Zipline Medical Inc. Partner with MVM Life Science Partners LLP.
  • Previous assignments (last five years): None.
  • Position: Independent of the Company and executive management. Dependent to major shareholders.
  • Holdings in the Company: None.

hans-schikan-photo

Hans Schikan

Born 1958. Board Member since 2015. Chairman of the remuneration committee.

  • Education: Pharm.D, Utrecht University.
  • Other current assignments: Chairman of the board of Asceneuron SA, InteRNA Technologies BV and Complix NV. Board member of Swedish Orphan Biovitrum AB (publ) and Hansa Medical AB (publ).
  • Previous assignments (last five years): CEO and board member of Prosensa Holding NV.
  • Position: Independent of the Company, executive management and major shareholders.
  • Holdings in the Company: 170,000 stock options and 16,000 performance shares Board LTIP 2016.

m-rten-steen-photo

Mårten Steen

Born 1975. Board Member since 2012. Member of the audit committee and the remuneration committee.

  • Education: MD, Ph.D. in clinical chemistry and B.Sc. in business administration, Lund University.
  • Other current assignments: Partner of HealthCap. Board member of HealthNeed AB, Strongbridge Biopharma Plc, Altimmune Inc and BioClin Therapeutics Inc. Deputy board member of Medacto AB.
  • Previous assignments (last five years): Board member of Cortendo AB (publ), FerroKin Inc, Glionova AB and Ultragenyx Inc.
  • Position: Independent of the Company and executive management. Dependent to major shareholders.
  • Holdings in the Company: None.